Literature DB >> 4159571

Cyclophosphamide in the management of advanced bronchial carcinoma.

R D McLean.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 4159571      PMCID： PMC1018984          DOI： 10.1136/thx.20.6.555

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  17 in total

1.  Use of cyclophosphamide in advanced malignancies.

Authors:  M ARONOVITCH; J F MEAKINS; M GROSZMAN
Journal:  Can Med Assoc J       Date:  1960-11-05       Impact factor: 8.262

2.  CYCLOPHOSPHAMIDE IN MALIGNANT DISEASE.

Authors:  J B HEALY
Journal:  Lancet       Date:  1964-01-11       Impact factor: 79.321

3.  The response of various types of bronchogenic carcinoma to nitrogen mustard.

Authors:  B LEVINE; A S WEISBERGER
Journal:  Ann Intern Med       Date:  1955-05       Impact factor: 25.391

4.  Oat cell lung cancer.

Authors:  W L WATSON; J W BERG
Journal:  Cancer       Date:  1962 Jul-Aug       Impact factor: 6.860

5.  [Trials in endoxan therapy].

Authors:  C WIELAND; S WIELAND
Journal:  Munch Med Wochenschr       Date:  1961-11-03

6.  Clinical experience with cyclophosphamide in malignant disease.

Authors:  D A DICK; A F PHILLIPS
Journal:  Can Med Assoc J       Date:  1961-10-28       Impact factor: 8.262

7.  [Clinical experiences with the cytostatic drug Endoxan].

Authors:  H DITTRICH
Journal:  Arzneimittelforschung       Date:  1961-03

8.  Treatment of malignant disease with an alkylating agent: review of 100 patients treated with "Endoxan".

Authors:  T S REEVE
Journal:  Med J Aust       Date:  1961-05-13       Impact factor: 7.738

9.  [Clinical experiences with endoxan].

Authors:  S ECKHARDT; C SELLEI; F HARTAI
Journal:  Munch Med Wochenschr       Date:  1959-12-04

10.  [Effect of a cyclic nitrogen mustard-phosphamidester on experimentally induced tumors in rats; chemotherapeutic effect and pharmacological properties of B 518 ASTA].

Authors:  N BROCK; H WILMANNS
Journal:  Dtsch Med Wochenschr       Date:  1958-03-21       Impact factor: 0.628
View more
  2 in total

Review 1.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

Review 2.  Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.

Authors:  Jie Jiang; John Ravits
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.